Coherex Medical brings in $16.5mm through its Series B
Coherex Medical (developed a device to repair heart defects) has raised $16.5mm through its Series B venture round of preferred stock. Current shareholders Oxford Bioscience Partners and vSpring Capital co-led the financing and were joined by new investor Tullis Health Investors.
- Medical Devices
- Implantable Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Venture Financing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.